
Canada Approves Funding Path for Rare Liver Disease Drug
Canadians with a rare liver disease that can lead to organ failure are one step closer to getting a new treatment covered by public health insurance. After successful national negotiations, the medication could become available through provincial drug plans as early as 2027.



